Review
Open access
Aug 2026
Claudin-18.2: Molecular mechanisms to clinical translation in solid tumors (Review)
This article systematically elaborates the molecular structure, expression regulatory mechanisms and clinicopathological value of CLDN18.2 based on the data of 58 global clinical trials, and analyzes the current status, existing problems in testing standardization and drug development.
Min-Jie Zhang, Da-Wei Wu, Yu Tang et al.
· Oncology Letters · 0 citations